FDA Inspection 1187473 — Huntsville Reproductive Medicine P.C.
The FDA completed an inspection of Huntsville Reproductive Medicine P.C. on Oct 26, 2022 in Madison, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 26, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Madison, AL (United States)